Inactivation of AKT induces cellular senescence in uterine leiomyoma

34Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

Abstract

Uterine leiomyomas (fibroids) are a major public health problem. Current medical treatments with GnRH analogs do not provide long-term benefit. Thus, permanent shrinkage or inhibition of fibroid growth via medical means remains a challenge. The AKT pathway is a major growth and survival pathway for fibroids. We propose that AKT inhibition results in a transient regulation of specific mechanisms that ultimately drive cells into cellular senescence or cell death. In this study, we investigated specific mechanisms of AKT inhibition that resulted in senescence. We observed that administration of MK-2206, an allosteric AKT inhibitor, increased levels of reactive oxygen species, up-regulated the microRNA miR-182 and several senescence-associated genes (including p16, p53, p21, and β-galactosidase), and drove leiomyoma cells into stress-induced premature senescence (SIPS). Moreover, induction of SIPS was mediated by HMGA2, which colocalized to senescence-associated heterochromatin foci. This study provides a conceivable molecular mechanism of SIPS by AKT inhibition in fibroids. Copyright © 2014 by the Endocrine Society.

Cite

CITATION STYLE

APA

Xu, X., Lu, Z., Qiang, W., Vidimar, V., Kong, B., Kim, J. J., & Wei, J. J. (2014). Inactivation of AKT induces cellular senescence in uterine leiomyoma. Endocrinology, 155(4), 1510–1519. https://doi.org/10.1210/en.2013-1929

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free